{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:36:27Z","timestamp":1787150187331,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00417-026-07201-8","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:20:05Z","timestamp":1776154805000},"page":"2361-2370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of expanded-field OCT angiography in visual acuity outcomes for non-proliferative diabetic retinopathy"],"prefix":"10.1007","volume":"264","author":[{"given":"Mauricio D.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridula","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Overbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Ploumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itika","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Vingopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"4","key":"7201_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ceo.12696","volume":"44","author":"DSW Ting","year":"2016","unstructured":"Ting DSW, Cheung GCM, Wong TY (2016) Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 44(4):260\u2013277. https:\/\/doi.org\/10.1111\/ceo.12696","journal-title":"Clin Exp Ophthalmol"},{"key":"7201_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1\u201355. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.11.003","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"7201_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1932296816629491","volume":"10","author":"JKH Goh","year":"2016","unstructured":"Goh JKH, Cheung CY, Sim SS, Tan PC, Tan GSW, Wong TY (2016) Retinal Imaging Techniques for Diabetic Retinopathy Screening. J Diabetes Sci Technol 10(2):282\u2013294. https:\/\/doi.org\/10.1177\/1932296816629491","journal-title":"J Diabetes Sci Technol"},{"key":"7201_CR4","doi-asserted-by":"publisher","first-page":"100951","DOI":"10.1016\/j.preteyeres.2021.100951","volume":"84","author":"I La\u00edns","year":"2021","unstructured":"La\u00edns I, Wang JC, Cui Y et al (2021) Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). Prog Retin Eye Res 84:100951. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100951","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"7201_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/08820538.2021.1887901","volume":"36","author":"M Wang","year":"2021","unstructured":"Wang M, Garg I, Miller JB (2021) Wide Field Swept Source Optical Coherence Tomography Angiography for the Evaluation of Proliferative Diabetic Retinopathy and Associated Lesions: A Review. Semin Ophthalmol 36(4):162\u2013167. https:\/\/doi.org\/10.1080\/08820538.2021.1887901","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"7201_CR6","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1038\/s41598-018-28530-7","volume":"8","author":"H Shiihara","year":"2018","unstructured":"Shiihara H, Terasaki H, Sonoda S et al (2018) Objective evaluation of size and shape of superficial foveal avascular zone in normal subjects by optical coherence tomography angiography. Sci Rep 8(1):10143. https:\/\/doi.org\/10.1038\/s41598-018-28530-7","journal-title":"Sci Rep"},{"issue":"8","key":"7201_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/IAE.0000000000001407","volume":"37","author":"Q You","year":"2017","unstructured":"You Q, Freeman WR, Weinreb RN, REPRODUCIBILITY OF VESSEL DENSITY MEASUREMENT WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH AND WITHOUT RETINOPATHY et al (2017) RETINA 37(8):1475. https:\/\/doi.org\/10.1097\/IAE.0000000000001407","journal-title":"RETINA"},{"issue":"11","key":"7201_CR8","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s00417-023-06086-1","volume":"261","author":"G Baldwin","year":"2023","unstructured":"Baldwin G, Vingopoulos F, Garg I et al (2023) Structure-function associations between contrast sensitivity and widefield swept-source optical coherence tomography angiography in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 261(11):3113\u20133124. https:\/\/doi.org\/10.1007\/s00417-023-06086-1","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"12","key":"7201_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1136\/bjo-2023-323900","volume":"108","author":"F Vingopoulos","year":"2024","unstructured":"Vingopoulos F, Baldwin G, Katz R et al (2024) Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy. Br J Ophthalmol 108(12):1708\u20131715. https:\/\/doi.org\/10.1136\/bjo-2023-323900","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7201_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1177\/11206721241228010","volume":"34","author":"S Wei-Zhang","year":"2024","unstructured":"Wei-Zhang S, He K, Zhou W et al (2024) Relationship between visual acuity and OCT angiography parameters in diabetic retinopathy eyes after treatment. Eur J Ophthalmol 34(5):1521\u20131531. https:\/\/doi.org\/10.1177\/11206721241228010","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"7201_CR11","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41433-024-02978-6","volume":"38","author":"F Romano","year":"2024","unstructured":"Romano F, Ding X, Miller JB (2024) Expanded field: filling the gap between macula and widefield. Eye 38(9):1612\u20131613. https:\/\/doi.org\/10.1038\/s41433-024-02978-6","journal-title":"Eye"},{"key":"7201_CR12","doi-asserted-by":"publisher","unstructured":"Kawai K, Murakami T, Mori Y et al (2023) Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy. Ophthalmol Sci 3(1). https:\/\/doi.org\/10.1016\/j.xops.2022.100241","DOI":"10.1016\/j.xops.2022.100241"},{"issue":"2","key":"7201_CR13","doi-asserted-by":"publisher","first-page":"100144","DOI":"10.1016\/j.xops.2022.100144","volume":"2","author":"I Garg","year":"2022","unstructured":"Garg I, Uwakwe C, Le R et al (2022) Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity. Ophthalmol Sci 2(2):100144. https:\/\/doi.org\/10.1016\/j.xops.2022.100144","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"7201_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41433-021-01649-0","volume":"36","author":"CC Wykoff","year":"2022","unstructured":"Wykoff CC, Yu HJ, Avery RL, Ehlers JP, Tadayoni R, Sadda SR (2022) Retinal non-perfusion in diabetic retinopathy. Eye 36(2):249\u2013256. https:\/\/doi.org\/10.1038\/s41433-021-01649-0","journal-title":"Eye"},{"issue":"1","key":"7201_CR15","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1038\/s41598-023-35286-2","volume":"13","author":"M Hein","year":"2023","unstructured":"Hein M, Vukmirovic A, Constable IJ et al (2023) Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema. Sci Rep 13(1):8128. https:\/\/doi.org\/10.1038\/s41598-023-35286-2","journal-title":"Sci Rep"},{"issue":"10","key":"7201_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.oret.2019.04.027","volume":"3","author":"YT Hsieh","year":"2019","unstructured":"Hsieh YT, Alam MN, Le D et al (2019) OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema. Ophthalmol Retina 3(10):826\u2013834. https:\/\/doi.org\/10.1016\/j.oret.2019.04.027","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"7201_CR17","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677\u20131682. https:\/\/doi.org\/10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"issue":"6","key":"7201_CR18","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.21037\/qims-21-1175","volume":"13","author":"I Garg","year":"2023","unstructured":"Garg I, Miller JB (2023) Semi-automated algorithm using directional filter for the precise quantification of non-perfusion area on widefield swept-source optical coherence tomography angiograms. Quant Imaging Med Surg 13(6):3688\u20133702. https:\/\/doi.org\/10.21037\/qims-21-1175","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"7201_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/IAE.0000000000003730","volume":"43","author":"JK Sun","year":"2023","unstructured":"Sun JK, Beaulieu WT, Melia M, DEFINING et al (2023) Retina Phila Pa 43(4):616\u2013623. https:\/\/doi.org\/10.1097\/IAE.0000000000003730","journal-title":"Retina Phila Pa"},{"issue":"5 Suppl","key":"7201_CR20","first-page":"786","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):786\u2013806","journal-title":"Ophthalmology"},{"issue":"9735","key":"7201_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376(9735):124\u2013136. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3","journal-title":"Lancet"},{"issue":"5","key":"7201_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jama.2022.25029","volume":"329","author":"RK Maturi","year":"2023","unstructured":"Maturi RK, Glassman AR, Josic K et al (2023) Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy. JAMA 329(5):376\u2013385. https:\/\/doi.org\/10.1001\/jama.2022.25029","journal-title":"JAMA"},{"key":"7201_CR23","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142025. Diabetes Care (2024) ;48(Supplement_1):S252-S265. https:\/\/doi.org\/10.2337\/dc25-S012","DOI":"10.2337\/dc25-S012"},{"issue":"4","key":"7201_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4103\/ijo.IJO_1403_20","volume":"69","author":"V Kumar","year":"2021","unstructured":"Kumar V, Surve A, Kumawat D et al (2021) Ultra-wide field retinal imaging: A wider clinical perspective. Indian J Ophthalmol 69(4):824\u2013835. https:\/\/doi.org\/10.4103\/ijo.IJO_1403_20","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"7201_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11892-015-0577-6","volume":"15","author":"DA Sim","year":"2015","unstructured":"Sim DA, Keane PA, Tufail A, Egan CA, Aiello LP, Silva PS (2015) Automated retinal image analysis for diabetic retinopathy in telemedicine. Curr Diab Rep 15(3):14. https:\/\/doi.org\/10.1007\/s11892-015-0577-6","journal-title":"Curr Diab Rep"},{"key":"7201_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajo.2024.02.012","volume":"263","author":"S Joseph","year":"2024","unstructured":"Joseph S, Selvaraj J, Mani I et al (2024) Diagnostic Accuracy of Artificial Intelligence-Based Automated Diabetic Retinopathy Screening in Real-World Settings: A Systematic Review and Meta-Analysis. Am J Ophthalmol 263:214\u2013230. https:\/\/doi.org\/10.1016\/j.ajo.2024.02.012","journal-title":"Am J Ophthalmol"},{"key":"7201_CR27","doi-asserted-by":"publisher","first-page":"434560","DOI":"10.1155\/2013\/434560","volume":"2013","author":"BL Sikorski","year":"2013","unstructured":"Sikorski BL, Malukiewicz G, Stafiej J, Lesiewska-Junk H, Raczynska D (2013) The Diagnostic Function of OCT in Diabetic Maculopathy. Mediators Inflamm 2013:434560. https:\/\/doi.org\/10.1155\/2013\/434560","journal-title":"Mediators Inflamm"},{"issue":"1","key":"7201_CR28","doi-asserted-by":"publisher","first-page":"e0210505","DOI":"10.1371\/journal.pone.0210505","volume":"14","author":"C Enders","year":"2019","unstructured":"Enders C, Lang GE, Dreyhaupt J, Loidl M, Lang GK, Werner JU (2019) Quantity and quality of image artifacts in optical coherence tomography angiography. PLoS ONE 14(1):e0210505. https:\/\/doi.org\/10.1371\/journal.pone.0210505","journal-title":"PLoS ONE"},{"issue":"2","key":"7201_CR29","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.xops.2021.100027","volume":"1","author":"Y Guo","year":"2021","unstructured":"Guo Y, Hormel TT, Gao L et al (2021) Quantification of Nonperfusion Area in Montaged Widefield OCT Angiography Using Deep Learning in Diabetic Retinopathy. Ophthalmol Sci 1(2):100027. https:\/\/doi.org\/10.1016\/j.xops.2021.100027","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"7201_CR30","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1038\/s41598-021-82334-w","volume":"11","author":"H Endo","year":"2021","unstructured":"Endo H, Kase S, Tanaka H et al (2021) Factors based on optical coherence tomography correlated with vision impairment in diabetic patients. Sci Rep 11(1):3004. https:\/\/doi.org\/10.1038\/s41598-021-82334-w","journal-title":"Sci Rep"},{"issue":"10","key":"7201_CR31","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s10792-018-1034-8","volume":"39","author":"D Gildea","year":"2019","unstructured":"Gildea D (2019) The diagnostic value of optical coherence tomography angiography in diabetic retinopathy: a systematic review. Int Ophthalmol 39(10):2413\u20132433. https:\/\/doi.org\/10.1007\/s10792-018-1034-8","journal-title":"Int Ophthalmol"},{"issue":"7","key":"7201_CR32","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.2337\/db14-0782","volume":"64","author":"JK Sun","year":"2015","unstructured":"Sun JK, Radwan SH, Soliman AZ et al (2015) Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema. Diabetes 64(7):2560\u20132570. https:\/\/doi.org\/10.2337\/db14-0782","journal-title":"Diabetes"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07201-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:22:39Z","timestamp":1787149359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07201-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7201"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07201-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of Massachusetts General Brigham approved the study (protocol: 2019P001863), and all participants provided written informed consent before their inclusion. Our procedures adhered to the principles outlined in the Declaration of Helsinki and complied with Health Insurance Portability and Accountability Act (HIPAA) regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"1. JBM is a consultant for Alcon, Allergan, Carl Zeiss, Sumitomo\/Sunovion, Topcon, and Genentech. 2. JWM is a consultant for Sumitomo Pharma America, Inc., ONL Therapeutics; and has received financial support from ONL Therapeutics, QLT\/Bausch and Lomb\/Mass. Eye and Ear, and Lowy Medical Research Institute. 3. DGV is a consultant for Olix Pharma, Valitor, Twenty, Sumitomo\/Sunovion, Cambridge Polymer Group; and has received financial support from National Eye Institute, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute.4. DH is a consultant for Allergan, Genentech, Omeicos Therapeutics; and has received financial support from National Eye Institute, Lions Vision Gift, Commonwealth Grant, Lions International, Syneos LLC, and the Macular Society.5. NAP is a consultant for Alimera Sciences, Alcon, Allergan, Genentech, Eyepoint, Lifesciences Guidepoint and GLG.6. LAK: has received research support from National Eye Institute, Department of Defense, Macula Society, CureVac AG, and Valo Health; and is a consultant for Pykus Therapeutics and Ingenia Therapeutics.8. MDG, XD, FR, MS, IG, JG, KMO, IP, FV, YZ, DMW have no relevant financial disclosures.","order":3,"name":"Ethics","label":"Financial disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}